Andrzej Hoczyk, External Supply Operations (ESO) Head at Polpharma, presented the case for treating large-scale tech transfer as a managed program rather than a series of parallel projects at CDMO Live Europe 2026, drawing on a five-year, 21-product sterile portfolio migration across five contract manufacturing sites.<a href="https://pharmasource.global/content/how-polpharma-transferred-21-products-across-five-cdmos-without-breaking-supply/" target="_blank" rel="noopener noreferer">Read more</a>.

Andrzej Hoczyk, External Supply Operations (ESO) Head at Polpharma, presented the case for treating large-scale tech transfer as a managed program rather than a series of parallel projects at CDMO Live Europe 2026, drawing on a five-year, 21-product sterile portfolio migration across five contract manufacturing sites. Read more.

Andrzej Hoczyk, External Supply Operations (ESO) Head at Polpharma, presented the case for treating large-scale tech transfer as a managed program rather than a series of parallel projects at CDMO Live Europe 2026, drawing on a five-year, 21-product sterile portfolio migration across five contract manufacturing sites.<a href="https://pharmasource.global/content/how-polpharma-transferred-21-products-across-five-cdmos-without-breaking-supply/" rel="noopener noreferrer">Read more</a>.

How Polpharma Transferred 21 Products Across Five CDMOs

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.

In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides.

Make sure to subscribe for your regular dose of pharma insight.

Science

Life Sciences

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing. In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides. Make sure to subscribe for your regular dose of pharma insight.

Share How Polpharma Transferred 21 Products Across Five CDMOs

Sign up to save your podcasts

How Polpharma Transferred 21 Products Across Five CDMOs

How Polpharma Transferred 21 Products Across Five CDMOs